FierceBiotech ٨ يناير ٢٠٢٦ WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities
FierceBiotech ٨ يناير ٢٠٢٦ Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
FierceBiotech ٧ يناير ٢٠٢٦ Pulmocide calls curtains on phase 3 antifungal trial over low response, higher mortality rate
FierceBiotech ٧ يناير ٢٠٢٦ Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
FierceBiotech ٧ يناير ٢٠٢٦ Staar Surgical's takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal
FierceBiotech ٧ يناير ٢٠٢٦ Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M
FierceBiotech ٧ يناير ٢٠٢٦ Hutchmed heats up autoimmune race with phase 3 win, teeing up China filing
FierceBiotech ٧ يناير ٢٠٢٦ GSK's 'functional cure' for hep B proves worth in phase 3 trials setting up approval push
FierceBiotech ٦ يناير ٢٠٢٦ Arrowhead takes aim at obesity market with early data on dual gene silencing assets
FierceBiotech ٦ يناير ٢٠٢٦ In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
FierceBiotech ٦ يناير ٢٠٢٦ Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
FierceBiotech ٦ يناير ٢٠٢٦ Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator
FierceBiotech ٦ يناير ٢٠٢٦ Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact